Key statistics
On Monday, Vistagen Therapeutics Inc (VTGN:NAQ) closed at 2.79, 13.87% above the 52 week low of 2.45 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.01 |
---|---|
High | 3.01 |
Low | 2.79 |
Bid | 2.78 |
Offer | 2.81 |
Previous close | 2.94 |
Average volume | 137.19k |
---|---|
Shares outstanding | 27.06m |
Free float | 26.99m |
P/E (TTM) | -- |
Market cap | 79.54m USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 20:17 BST.
More ▼
Press releases
- Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day
- Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
- Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update
- Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024